CAH · Cardinal Health Inc · Documents

Jan 30

Quarterly report 10-Q FY2025 Q2, ended Dec 31

Quarterly report for FY2025 Q2

Revenue $55.26B ▼ 3.8% Net income $400M ▲ 8.7%

Jan 14

Current report 8-K

Regulation FD disclosure

Dec 9

Current report 8-K Events of Dec 5

Entered into a material agreement, New debt or off-balance-sheet obligation

Nov 22

Current report 8-K

Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation

Nov 18

Current report 8-K Events of Nov 13

Other events

Nov 12

Current report 8-K Events of Nov 11

Entered into a material agreement, Regulation FD disclosure

Nov 7

Current report 8-K Events of Nov 6

Shareholder vote results

Nov 1

Earnings call

Q1 2025 earnings call

Nov 1

Current report 8-K

Financial results, Regulation FD disclosure

Nov 1

Quarterly report 10-Q FY2025 Q1, ended Sep 30

Quarterly report for FY2025 Q1

Revenue $52.28B ▼ 4.3% Net income $416M Diluted EPS $1.70

Oct 23

Proxy statement DEFA14A

Proxy statement

Oct 10

Current report 8-K Events of Oct 8

Entered into a material agreement, New debt or off-balance-sheet obligation

Oct 2

Proxy statement DEFA14A

Proxy statement

Sep 16

Proxy statement DEF 14A Meeting Nov 6, 2024

Proxy statement

Sep 16

Annual report to holders ARS

Annual report to holders

Sep 16

Proxy statement DEFA14A

Proxy statement

Sep 9

Current report 8-K Events of Sep 6

Director or officer change, or executive pay

Aug 14

Earnings call

Q4 2024 earnings call

Aug 14

Current report 8-K

Financial results, Regulation FD disclosure

Aug 14

Annual report 10-K FY2024, ended Jun 30

Annual report for FY2024

Revenue $226.83B ▲ 10.7% Net income $852M ▲ 158.2% Diluted EPS $3.45 ▲ 173.8%

May 2

Earnings call

Q3 2024 earnings call

May 2

Current report 8-K

Financial results, Regulation FD disclosure

May 2

Quarterly report 10-Q FY2024 Q3, ended Mar 31

Quarterly report for FY2024 Q3

Revenue $54.91B ▲ 8.8% Net income $258M ▼ 25.2%

Apr 23

Current report 8-K

Regulation FD disclosure

Apr 22

Current report 8-K

Regulation FD disclosure

Feb 28

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Feb 20

Current report 8-K Events of Feb 14

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Feb 1

Earnings call

Q2 2024 earnings call

Feb 1

Current report 8-K

Financial results, Regulation FD disclosure

Feb 1

Quarterly report 10-Q FY2024 Q2, ended Dec 31

Quarterly report for FY2024 Q2

Revenue $57.45B ▲ 11.6% Net income $353M

Jan 9

Current report 8-K

Financial results, Regulation FD disclosure

Nov 16

Current report 8-K Events of Nov 15

Shareholder vote results

Nov 3

Earnings call

Q1 2024 earnings call

Nov 3

Current report 8-K

Financial results, Regulation FD disclosure

Nov 3

Quarterly report 10-Q FY2024 Q1, ended Sep 30

Quarterly report for FY2024 Q1

Revenue $54.76B ▲ 10.4% Net income $5M ▼ 95.5% Diluted EPS $0.02 ▼ 95.0%

Oct 12

Proxy statement DEFA14A

Proxy statement

Oct 10

Proxy statement DEFA14A

Proxy statement

Sep 27

Proxy statement DEF 14A Meeting Nov 15, 2023

Proxy statement

Sep 27

Annual report to holders ARS

Annual report to holders

Sep 27

Proxy statement DEFA14A

Proxy statement

Sep 6

Current report 8-K Events of Sep 1

Entered into a material agreement

Aug 15

Earnings call

Q4 2023 earnings call

Aug 15

Current report 8-K Events of Aug 10

Financial results, Director or officer change, or executive pay, Regulation FD disclosure

Aug 15

Annual report 10-K FY2023, ended Jun 30

Annual report for FY2023

Revenue $205.01B ▲ 13.0% Net income $261M Diluted EPS $1.00

Jun 8

Current report 8-K

Regulation FD disclosure

May 11

Current report 8-K

Charter or bylaw amendment, or fiscal year change

May 4

Earnings call

Q3 2023 earnings call

May 4

Current report 8-K Events of May 3

Entered into a material agreement, Financial results, Regulation FD disclosure

May 4

Quarterly report 10-Q FY2023 Q3, ended Mar 31

Quarterly report for FY2023 Q3

Revenue $50.49B ▲ 12.6% Net income $345M

Mar 2

Current report 8-K Events of Feb 27

Entered into a material agreement